Related Experiment Video
Updated: Apr 29, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Peri-procedural management of anti-platelets and anticoagulation in patients undergoing MitraClip procedure
1Division of Cardiovascular Health and Disease, University of Cincinnati College of Medicine, 231 Albert Sabine Way, Cincinnati, OH, 45267, USA, alsidasd@ucmail.uc.edu.
Abstract:
The MitraClip device was recently approved by the FDA for the management of severe degenerative mitral regurgitation in patients considered to be high risk for surgical repair or replacement of the mitral valve. The management of anti-platelet and anticoagulant therapy before, during, and after the MitraClip placement is not well defined given the lack of evidence from large randomized trials. In this paper, we propose practical management guidelines for using these agents.
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Mitral Stenosis III: Medical Management
Peripheral Artery Disease III: Interprofessional Care
Aneurysm IV: Nursing Management
Mitral Regurgitation III: Medical Management
Venous Thrombosis III: Interprofessional Care

